RESEARCH MONOGRAPH · KDC-MN-166

Dynamine (Methylliberine)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

47/100

A branded methylxanthine cousin with thin data and aggressive marketing claims

Dynamine is the branded name for methylliberine, a purine alkaloid found in kucha tea alongside theacrine. Structurally it's similar to caffeine and theacrine, with the same general purine backbone and a methylation pattern that puts it in the adenosine-receptor-active family.

The marketing claim is that it works faster than caffeine and faster than theacrine, with similar alertness effects and lower side-effect burden. The mechanism story they tell is adenosine receptor antagonism plus some dopaminergic modulation, which is the same story everyone tells about every methylxanthine, and honestly it's probably partially true here.

The human data is genuinely thin. There are two or three short studies sponsored by Compound Solutions (who developed and licenses Dynamine) showing acute alertness and mood effects in the 100-150mg range, mostly co-administered with caffeine or theacrine. There's a small safety study showing no concerning cardiovascular signal at 100mg/day for 8 weeks. That's about it. No independent academic group has done meaningful work on this molecule that we're aware of, which is a real gap.

The fast-onset claim is interesting but unverified outside the manufacturer's studies. Pharmacokinetically you'd expect a methylxanthine to have absorption kinetics similar to caffeine, and the proposed faster onset is more about subjective alertness than measured plasma curves.

Sourcing-wise this is one of the most locked-down ingredient stories in supplements right now. Dynamine specifically is a Compound Solutions branded ingredient. Bulk methylliberine from non-licensed sources is rare and quality is hard to verify. HPLC analysis is doable but reference standards are not widely available, which complicates QC.

Safety: limited human data, no signal of trouble at studied doses, but the long-term profile is genuinely unknown.

What we like: a new methylxanthine variant with potentially different kinetics is genuinely scientifically interesting, and we'd love to see academic work on the receptor profile. What we dont like: the supplement positioning has run far ahead of the data, the studies are all sponsored by the patent holder, and the molecule has not had independent characterization in any depth.

Treat it as an early-stage research compound. The marketing has skipped about three years of replication that hasnt happened.

Evidence: 30
Mechanism: 50
Reliability: 45
Safety: 60
Sourcing: 55
Value: 45
Signal: 45
Staying power: 45

Plain-language summary Intrigue 38 / 100

Dynamine (methylliberine) is a purine alkaloid related to theacrine, marketed in pre-workout formulations as a longer-lasting alternative to caffeine. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Purine alkaloid (methylliberine)

A purine alkaloid related to theacrine, present in kucha tea, marketed as Dynamine for energy and focus applications.

Abstract

Dynamine (methylliberine; 9-methylliberine) is a purine alkaloid related to theacrine and present in kucha tea (Camellia kucha). The compound is marketed as Dynamine by Compound Solutions for energy and focus applications. Pharmacology likely overlaps with the broader methylxanthine class (adenosine antagonism) but specific receptor profile and clinical evidence base are limited. Reported research dose ranges in the literature span 50 to 200 mg; Compound Solutions describes it as having faster onset than theacrine.

Mechanism of action

Purine alkaloid; adenosine receptor antagonism presumed.

Reported research dose ranges

Reported research dose ranges in the literature span 50 to 200 mg.

References

Compound Solutions Dynamine product literature. Limited peer-reviewed characterization.

Read the full monograph

Available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-166

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Dynamine (Methylliberine)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs